<DOC>
	<DOCNO>NCT02259075</DOCNO>
	<brief_summary>Chronic migraine many case disable condition . Chronic migraine define headache least 15 day per month , 8 day typical migraine feature . In many case , oral drug treatment little effect . The parasympathetic nervous system act sphenopalatine ganglion may involve several primary headache , include migraine , facilitate release inflammatory substance cerebral vessel . Botulinum toxin type A ( BTA ) inhibit excretion acetylcholine result block nerve signal sphenopalatine ganglion . The purpose present study evaluate new technique injection BTA use minimal invasive image guide procedure , block sphenopalatine ganglion . The goal relieve migraine symptom develop alternate treatment case oral drug treatment fail . The main objective project determine safety method BTA injection area sphenopalatine ganglion detect adverse event . Secondary objective measure change headache attack parameter novel method .</brief_summary>
	<brief_title>Botox Injection Treatment Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Informed write consent Chronic migraine without aura define International Classification Headache Disorders ( ICHD ) 3 criterion Failed least 3 oral migraine prophylactic treatment Duration migraine least 1 year inclusion Start migraine participant turn 50 year Participant make distinction migraine type headache If criterion medicationoveruse headache ( MOH ) fulfil Heart lung disease Any kind systematic local disease illness may significantly increase risk complication procedure relate injection Psychiatric illness hinders participation study Known pregnancy breast feed Inadequate use contraceptive Overuse abuse opioids Abuse medication , narcotic alcohol Anomalies hinder impede use method injection Allergy hypersensitivity reaction marcain , lidocaine , xylocain adrenalin , botulinum toxin type A , Botox 's constituent related medication Treatment medication interact botulinum toxin type A</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Migraine aura</keyword>
	<keyword>Migraine without aura</keyword>
	<keyword>Headache disorder</keyword>
	<keyword>Botulinum Toxin Type A</keyword>
	<keyword>Sphenopalatine Ganglion Block</keyword>
	<keyword>Autonomic Nerve Block</keyword>
</DOC>